{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:15:59Z","timestamp":1777947359066,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018821","name":"Frankfurter Stiftung f\u00fcr krebskranke Kinder","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018821","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["101005077"],"award-info":[{"award-number":["101005077"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jinf.2022.07.023","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T02:20:46Z","timestamp":1659234046000},"page":"573-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants"],"prefix":"10.1016","volume":"85","author":[{"given":"Denisa","family":"Bojkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Stack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3587-7139","authenticated-orcid":false,"given":"Tamara","family":"Rothenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Kandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Ciesek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark N.","family":"Wass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-5888","authenticated-orcid":false,"given":"Martin","family":"Michaelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"jr.","given":"Jindrich","family":"Cinatl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2022.07.023_bib0001","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3390\/cells9112377","article-title":"Aprotinin inhibits SARS-CoV-2 replication","volume":"9","author":"Bojkova","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jinf.2022.07.023_bib0002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41421-022-00408-z","article-title":"SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment","volume":"8","author":"Bojkova","year":"2022","journal-title":"Cell Discov"},{"issue":"3","key":"10.1016\/j.jinf.2022.07.023_bib0003","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41422-022-00619-9","article-title":"Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates","volume":"32","author":"Bojkova","year":"2022","journal-title":"Cell Res"},{"key":"10.1016\/j.jinf.2022.07.023_bib0004","doi-asserted-by":"crossref","unstructured":"Bojkova D, Reus P, Panosch L, Bechtel M, Rothenburger T, Kandler J, et\u00a0al. Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform. bioRxiv. 2022b Jul 17:2022.07.17.500346. doi:10.1101\/2022.07.17.500346.","DOI":"10.1101\/2022.07.17.500346"},{"issue":"12","key":"10.1016\/j.jinf.2022.07.023_bib0005","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S2213-2600(21)00384-2","article-title":"ACTT-3 study group members. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial","volume":"9","author":"Kalil","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.jinf.2022.07.023_bib0006","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00000542-199405000-00010","article-title":"Pharmacokinetics of aprotinin in preoperative cardiac surgical patients","volume":"80","author":"Levy","year":"1994","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.jinf.2022.07.023_bib0007","doi-asserted-by":"crossref","first-page":"e13776","DOI":"10.1111\/eci.13776","article-title":"Aprotinin treatment against SARS-CoV-2: a randomized phase III study to evaluate the safety and efficacy of a pan-protease inhibitor for moderate COVID-19","volume":"52","author":"Redondo-Calvo","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jinf.2022.07.023_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2022.07.014","article-title":"Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment","author":"Vellas","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2022.07.023_bib0009","doi-asserted-by":"crossref","unstructured":"White JM, Schiffer JT, Bender Ignacio RA, Xu S, Kainov D, Ianevski A, et\u00a0al. Drug combinations as a first line of defense against coronaviruses and other emerging viruses. mBio. 2021 Dec 21;12(6):e0334721. doi:10.1128\/mbio.03347-21.","DOI":"10.1128\/mbio.03347-21"},{"issue":"6","key":"10.1016\/j.jinf.2022.07.023_bib0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322004558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322004558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:34:58Z","timestamp":1759008898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445322004558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0163445322004558"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2022.07.023","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.22.501169","asserted-by":"object"}]},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2022.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}